Health
Third major COVID-19 vaccine shown to be effective and cheaper – The Australian Financial Review
Early studies show the Oxford vaccine is slightly less effective than the other two – but it does not need special refrigeration and is far cheaper, conditions…
Pfizer and Moderna last week reported preliminary results from late-stage trials showing their vaccines were almost 95 per cent effective. But, unlike its rivals, the AstraZeneca vaccine doesn’t have to be stored at ultra-cold temperatures, making it easier to distribute, especially in developing countries.
The Australian government also has deals with Pfizer and Moderna to potentially deliver 134 million doses of these vaccines at a cost of $3.2 billion.
I think these are really exciting results,…
-
Business22 hours agoForget CBA and buy these high-yield ASX dividend shares
-
General23 hours agoWhy an Australian journalist is teaching meditation in America’s toughest jails
-
Noosa News23 hours ago“There’s No Going Back”: The Grid Meets the Real World in the Initial Trailer for Third ‘TRON’ Movie ‘Ares’
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 6 April 2025